We already know enough to act. Funders, institutions, research ethics committees, medical journals and publishers, individual researchers and clinicians—as is the case with clinical platform trials—can all play a part (doi:10.1136/bmj.p1809). And they must play it now. The under-representation of women in research is a status quo that is more accurately described as an enduring international scandal.”


This is the final post in a small series based on a recent BMJ editorial “Under-representation of women in research: a status quo that is a scandal” by Kamran Abbasi, in which he writes about the failings of medical research.

🔗 Editorial